Recent BioUtah News & Events

BioUtah, along with 10 Utah biotech and biopharma companies, have sent letters to Utah’s U.S. Senators and Representatives urging opposition to the President’s directive to impose “most-favored nation” pricing on Medicare Part B drugs. The letter notes that if the executive order moves forward, investment dollars for Utah’s smaller drug discovery companies could dry up […]

On August 11, Altitude Lab, founded by BioUtah member Recursion and the University of Utah’s Center for Technology & Venture Commercialization (TVC),  announced its first resident companies and opened applications for its unique collaborative facility and program. The incubator, a state-of-the-art 14,500 square foot lab facility, will offer resident companies workshops, mentoring, and non-dilutive funding […]

After IPO issuances came to a near-halt in late Q1 and early Q2, the window reopened wide this summer, when much-needed liquidity infused the markets and led to one of the strongest months for IPOs in 13 years. Join us for a two-part executive webcast series on the novel challenges of capital raising during a […]

Shop In Utah: $35M (+ $10M added from ComRent) Opened Monday, July 27 – closed August 7, 2020, at 1:30 p.m. Shop in Utah number of applications received: 872 Shop in Utah total award amount requested: $42,344,434 Shop in Utah number of awards: 653 Shop in Utah total award amount: $26,790,444 Average award amount: $41,023 […]

Recursion and University of Utah found incubator to propel new generation of life sciences in the region August 12, 2020 04:18 PM Eastern Daylight Time SALT LAKE CITY–(BUSINESS WIRE)–BioUtah President and CEO, Kelvyn Cullimore, issued the following statement following the announcement of the opening of Altitude Lab. “This is truly a life sciences milestone in […]

Bipartisan legislation to help entrepreneurs and startups navigate the economic perils of COVID-19, has been introduced in the U.S. House of Representatives. The bill, the IGNITE American Innovation Act (H.R. 7917), introduced by Reps. Dean Phillips (D-MN) and Jackie Walorski (R-IN), will allow many small companies that have not benefited from CARES Act relief to […]

BioUtah members are eligible for an exclusive discounted rate on our premiere BIO Investor Forum Digital registration package! HOW IT WORKS: Anyone can fill out the form to request a 20% discount. They will receive a discount code via email upon  completing the form. BIO will honor this code and rate up until showtime. Codes […]

Company Presentations are an integral programming element at BIO Investor Forum Digital that allow companies to discuss their pipeline, R&D activities, and future fundraising goals to this exclusive audience of investors and collaboration partners. Learn more and apply to present here.

Convergence is the largest annual gathering of regulatory professionals, regulators, scientists, and innovators from around the world and the only US event that is exclusively dedicated to the regulatory profession. And this year, the community will converge online with two virtual registration options that will allow attendees to experience Convergence live online from the safety […]

Take a quick lunch break to hear from Mike Leavitt (former U.S. Secretary of Health and Human Services and former Utah Governor) as he takes 20 minutes to discuss “Public Health: The Invisible Ingredient in Value-Based Care” in this free webinar. Learn more and register here.

This months Fulfillment Friday by NOW CFO features Michelle Lockhart. Michelle will presenting Healthy Hacks for Busy People. “As individuals, we each interpret success differently. But, no matter who you are, what your goal is and how you define success, one thing holds true: a healthy body and mind is essential if you want to […]

At a July 30 White House Roundtable, plasma industry leader and CSL Behring (CSL) CEO Paul Perreault, urged people who have recovered from COVID-19 to consider donating plasma to help develop a potential treatment for people with serious complications from COVID-19. Representing the plasma industry, Perreault pointed to the unprecedented CoVIg-19 Plasma Alliance – an […]

Earlier this week, Senate Majority Leader Mitch McConnell released the Republican version of a fourth COVID-19 package (or as some say, a second round of a CARES Act stimulus bill). The bill, titled the Health, Economic Assistance, Liability Protection, and Schools (HEALS) Act is actually a collection of bills. Highlights include another round of $1200 […]

Last Friday, President Trump signed four executive orders aimed at lowering drug prices, including an order that would set up a “most favored nation” (MFN) pricing model for Medicare Part B drugs, effectively imposing foreign price controls on critical medicines for seniors. The goal, Trump said, is to “end global freeloading on the backs of […]

Exciting news comes our way this week with the announcement by BioUtah member, Renalytix AI (Renalytix), that the company is going public with a global offering of an aggregate of 11,000,000 new ordinary shares – U.S. IPO priced at $13.50 per ordinary share, and a concurrent private placement in Europe and other countries outside of […]

On July 22, Pfizer and BioNTech announced the execution of an agreement with the HHS and DOD to meet the U.S. government’s Operation Warp Speed program goal to begin delivering 300 million doses of a vaccine for COVID-19 in 2021. Under the agreement, the U.S. government will receive 100 million doses of BNT162, the COVID-19 […]

Last week, BioUtah News and Events, reported that a number of new grant programs established by the Utah State Legislature would be soon open for applications through the Governor’s Office of Economic Development (GOED).  This week, detailed information on three of the programs, ComRent, Safe In Utah, and Shop In Utah have come online. In […]

As reported by The Hill, “White House and Senate Republicans on Thursday reached a “fundamental agreement” on a coronavirus package…” Among other items, the agreement includes: Another round of $1200 in direct payments to individuals making up to $75,000 Replacing the current $600 in federal unemployment benefits with a 70% match of a worker’s wages […]

While the drug pricing issue has been sidelined amid the COVID-19 pandemic, President Trump is now returning to the issue with several executive orders that he is expected to sign today. According to a report by The Hill, Republican lawmakers have been invited to a presidential event on drug pricing today at 3 p.m. at […]

This week Sens. Elizabeth Warren and Bernie Sanders sent a letter to HHS Secretary Alex Azar seeking an explanation for why the deal with the administration to acquire a large supply of remdesivir in their words “forces U.S. purchasers to pay the highest prices in the world for the drug” The letter requests a response […]

Article written by Janelle Bentz, Nelson Labs What is the difference between a medical face mask and respirator, and how and when they should be used?  The quick answer is medical face masks are meant to protect others and your environment; respirators are meant to protect the wearer.  A medical face mask helps reduce contamination […]

The CEO of a Utah medical device manufacturer recently stepped down from his duties. The reason? He had passed 100 days battling COVID-19 and was still symptomatic. This CEO was the picture of physical fitness.  In his early 50’s, with no underlying medical conditions, he would have been the type of person that one would […]

After leaving quite an impression to the attendees of the 2020 Entrepreneur and Investor Summit, we brought Monica DiCenso, managing director and head of Global Investment Opportunities Group at J.P. Morgan, back for a mid-year update on the stock market. In the webinar, Ms. Dicenso provided important insight into the rebound of the economy since […]

The China IVD market has seen record growth recently and will continue to be an important market with the growing threat of cancer and COVID-19. Join us on Thursday, July 23 at 11 a.m. EDT for the free webinar: China IVD Registration Pitfalls and COVID-19 Test Kit Updates. Attendees will receive comprehensive IVD guidance based on NMPA’s […]

The Utah Department of Health (UDOH) released a COVID-19 Business Manual – a step-by-step plan to help business mitigate the spread of COVID-19 and make their worksite as safe as possible for employees and customers. The manual is applicable during all color-coded phases of the pandemic and includes up-to-date recommendations from the UDOH, CDC, OHSA, […]

The recently launched statewide ‘In Utah’ campaign encourages protecting public health and economic reactivation as we continue to navigate COVID-19. BIoUtah has joined the ‘InUtah’ campaign as a partner to help get the word out and promote our own life sciences community. The campaign’s purpose is to educate Utahns on the opportunities and benefits of […]

On Tuesday, Moderna announced promising results from the Phase 1 study of its vaccine candidate, called mRNA-1273. The study, published in The New England Journal of Medicine  showed that all 45 volunteers who received two vaccine doses developed immune responses that were stronger than in patients who have recovered from COVID-19. “These positive Phase 1 […]

New and improved grant programs, aimed at providing economic support to Utah businesses impacted by COVID-19, are being finalized under the Governor’s Office of Economic Development (GOED). These programs, a result of legislation, HB 5010, which passed the state legislature during a June special session, include a revamped Commercial Rental Assistance Program (ComRent), making it […]

BioMerieux announced that Utah-based BioFire’s Respiratory Panel 2.1 plus, which tests for SARS-CoV-2 and 23 pathogens encompassing 19 viruses, and four bacteria that cause the most frequent respiratory tract infections, has received CE marking.  “It’s exciting to see the advances that BioFire is making in COVID-19 and infectious disease diagnostics,” said Kelvyn Cullimore, president and […]

This week, PhotoPharmics announced a collaboration with the Center for Health + Technology (CHeT) at the University of Rochester Medical Center to conduct an at home, telemedicine, phase 3 trial for the company’s Celeste® – a non-invasive, specialized light therapy device for Parkinson’s. The trial follows an FDA Breakthrough Device Designation for the device in […]

Last month, Johnson & Johnson (J&J) announced that its Phase 1/2a in-human clinical trial of its potential COVID-19 vaccine was expected to begin in July – instead of September as initially scheduled. On Thursday, as reported by Fierce Pharma, J&J chief scientific officer Paul Stoffels confirmed the accelerated timeline, saying that the company has seen […]

U.S. Pfizer and Germany’s BioNTech announced Monday that they have received Fast Track designation from the FDA for two COVID-19 vaccine candidates – BNT162b1 and BNT162b2 – part of the companies’ “Project Lightspeed” program. The designation was issued based on promising preliminary data from Phase 1/2 clinical studies. The FDA’s Fast Track designation is intended […]